Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma. - Wikidata - awgldk - TriplyDB

Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma.

Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma.

http://www.wikidata.org/entity/Q37363872

about

Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer Molecular interaction of a kinase inhibitor midostaurin with anticancer drug targets, S100A8 and EGFR: transcriptional profiling and molecular docking study for kidney cancer therapeutics Activation of Akt1 accelerates carcinogen-induced tumorigenesis in mammary gland of virgin and post-lactating transgenic mice Is there an association between enhanced choline and β-catenin pathway in breast cancer? A pilot study by MR Spectroscopy and ELISA.EGFR protein overexpression correlates with chromosome 7 polysomy and poor prognostic parameters in clear cell renal cell carcinoma.Mitochondrial translocation of EGFR regulates mitochondria dynamics and promotes metastasis in NSCLC Preclinical PET imaging of EGFR levels: pairing a targeting with a non-targeting Sel-tagged Affibody-based tracer to estimate the specific uptake.ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer.Expression and clinical value of EGFR in human meningiomas.Crossing paths in Human Renal Cell Carcinoma (hRCC).EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1).EGFR expression is linked to osteopontin and Nf-κB signaling in clear cell renal cell carcinoma.Multiple biomarker tissue arrays: A computational approach to identifying protein-protein interactions in the EGFR/ERK signalling pathway.Targeting aggressive prostate cancer-associated CD44v6 using phage display selected peptides.EGFR and Cortactin: Markers for potential double target therapy in oral squamous cell carcinoma.Evaluation of EGFR, KRAS and BRAF gene mutations in renal cell carcinoma.QSurface: fast identification of surface expression markers in cancers.Klotho inhibits EGF-induced cell migration in Caki-1 cells through inactivation of EGFR and p38 MAPK signaling pathways.Development of a Target cell-Biologics-Effector cell (TBE) complex-based cell killing model to characterize target cell depletion by T cell redirecting bispecific agents

P2860

Q28084216-5DABD42C-C692-45DA-AE2D-B6A13E5D9066 Q28544659-3B5261BA-EE9C-4140-AF70-778711A94FE8 Q33612060-5776024B-9C9F-472D-8329-0BF0FEBFBB66 Q33714951-B6B7C780-DDCC-412B-92FD-DC7BA9505D7D Q36012470-A4D0CABB-6F0C-4EC9-8792-A1FE6638E1CF Q36545739-AA7C55A8-FEDC-47BD-9CEB-55D71100AECD Q37075379-3C5B32B2-3668-4C07-B111-4017FF58FD9A Q37725589-99CFA5E2-2D81-49A7-A818-A44A6AFBF439 Q37732068-5CFFD6F6-937D-4834-9C8B-9E99FB24A26B Q38064316-D27300F0-F622-465D-A122-1F1FF795EA7D Q38989173-FC636645-7D9B-4850-9C50-5C2BFF76729C Q39303908-1C61FA2B-ED5C-4C5B-97CF-847ADF71D73F Q41338172-66E7E636-E125-43B7-99AB-072FBC087334 Q44262180-C43DC629-E992-4FC2-A2E2-60792AA9F705 Q49516085-7F18AAF1-CA85-47D6-B16A-CFAFAFB6C4A4 Q51763288-36B9F738-DED2-4F00-A9E8-D89250FB65F8 Q53078041-CBAA0E47-5293-471B-BA03-19C4D4FE5AD5 Q55253540-CED6C2F5-7E30-4043-826C-4573054CF1BC Q58726545-801528F7-4D65-4EEB-A614-B1C88FEACC48

P2860

Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma.

http://www.wikidata.org/entity/Q37363872

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Characterization of membranous ...... rtex and renal cell carcinoma.

@en

Characterization of membranous ...... rtex and renal cell carcinoma.

@nl

type

label

Characterization of membranous ...... rtex and renal cell carcinoma.

@en

Characterization of membranous ...... rtex and renal cell carcinoma.

@nl

prefLabel

Characterization of membranous ...... rtex and renal cell carcinoma.

@en

Characterization of membranous ...... rtex and renal cell carcinoma.

@nl

P1433

Q37363872-49786373-1FDC-4187-8BB9-80D7424D2926

P1476

Q37363872-8491AFEF-7630-4F82-8DBA-B018B1E1D3B4

P2093

Q37363872-0EE0E0FB-BCAF-4F0C-9064-4C9B9F5192D5

Q37363872-13786CC6-C2FD-4129-81AD-770A956A151C

Q37363872-32D1F001-14FB-4B4F-9018-81013F1C46AB

Q37363872-3AC41F8C-4853-44DC-B58D-7F8CD8EFBE00

Q37363872-410A2F32-A041-4027-9D6D-EC63DEB75AE0

Q37363872-4A9DA9F5-B236-4B05-8BBB-376D5118B857

Q37363872-7FE94C7C-BD6D-4B28-A63F-AF5B1E3D8090

Q37363872-92AD4812-35E8-416F-94F9-EADE4DF36405

Q37363872-C12A6EDC-3C84-4AB1-9575-1BD7D45674E7

Q37363872-C9BF3489-6FD6-4971-B346-C4BC33F792B5

P2860

Q37363872-0062328A-DAB4-48DE-8571-45CBEE7B0CCC

Q37363872-032BB86A-C307-4E51-9E48-B81F6EF3CAD5

Q37363872-07D20218-B0F7-4132-8FD3-51331CBFCA30

Q37363872-0A22194F-BA0D-452C-855F-56E0F6E5E510

Q37363872-11780CDB-BD8D-4954-BB05-2068FDF719FC

Q37363872-13F2DF16-3A36-4C2E-91BF-3756BADA72C3

Q37363872-1472092D-636D-4764-84DD-A60E912C33F9

Q37363872-21B73077-E4FC-4149-9E0D-8E6FCDF04E92

Q37363872-24FE6D0A-2655-4E71-988C-C3252899C8D9

Q37363872-29B18800-0352-413C-9EFD-63635326511B

P2888

Q37363872-811ABECF-2A64-4528-A3F9-5B2B1EFE6ED7

P304

Q37363872-6BA2A930-5233-40AA-AC19-FCAE8CC68C25

P31

Q37363872-6FC93DB5-0A80-432E-8F30-C00692872EB3

P356

Q37363872-F10F4513-4224-4A8C-AA70-6CAD9CD6930F

P478

Q37363872-5B2F93F7-F43E-4007-8E7A-55680B4DAE2D

P577

Q37363872-3A027027-258A-4936-AE32-AEC2F5FB1A49

P5875

Q37363872-A185CE8F-8C87-4D72-ABDF-AFC086E4E7E0

P6179

Q37363872-95C56BC1-EC7C-4637-BAC8-ECDF04E9D201

P698

Q37363872-9AD2F189-FD1B-4320-97D1-0B71907F53EA

P932

Q37363872-6BE676ED-2582-4A66-9608-021A620D0AEF

P356

1423-0127-16-82

P1433

Journal of Biomedical Science

P1476

Characterization of membranous ...... rtex and renal cell carcinoma.

@en

P2093

A-Mei Huang

http://www.w3.org/2001/XMLSchema#string

Chao-Yuan Huang

http://www.w3.org/2001/XMLSchema#string

Guang-Yaw Liu

http://www.w3.org/2001/XMLSchema#string

Hong-Jeng Yu

http://www.w3.org/2001/XMLSchema#string

Ming-Kuen Lai

http://www.w3.org/2001/XMLSchema#string

Shean-Jaw Chiou

http://www.w3.org/2001/XMLSchema#string

Shu-Pin Huang

http://www.w3.org/2001/XMLSchema#string

Tzyh-Chyuan Hour

http://www.w3.org/2001/XMLSchema#string

Wang-Yi Kang

http://www.w3.org/2001/XMLSchema#string

Wen-Jeng Wu

http://www.w3.org/2001/XMLSchema#string

P2860

EGFR antagonists in cancer treatment

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities.

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

Targeted therapy for metastatic renal cell carcinoma.

Prognostic significance of morphologic parameters in renal cell carcinoma.

Prognostic factors and molecular markers for renal cell carcinoma.

Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands.

Renal cell carcinoma: new prognostic factors?

Defective downregulation of receptor tyrosine kinases in cancer

Molecular markers for early detection of renal carcinoma: investigative approach.

P2888

1423-0127-16-82

P304

82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1423-0127-16-82

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26805635

http://www.w3.org/2001/XMLSchema#string

P6179

1050487518

http://www.w3.org/2001/XMLSchema#string

P698

19747398

http://www.w3.org/2001/XMLSchema#string

P932

2752453

http://www.w3.org/2001/XMLSchema#string